Research Topics
| S L AbbondanzoSummaryAffiliation: Armed Forces Institute of Pathology Country: USA Publications
| Collaborators
|
Detail Information
Publications
Silicone gel-filled breast and testicular implant capsules: a histologic and immunophenotypic studyS L Abbondanzo
Department of Hematopathology, Armed Forces Institute of Pathology, Washington, DC 20306 6000, USA
Mod Pathol 12:706-13. 1999..These findings suggest that silicone implants induce chronic inflammatory responses in many adjacent capsules, which consist of anamnestically responding T cells, reactive B-lymphocytes, and macrophages...
Low-grade B-cell lymphoma with coexpression of both CD5 and CD10. A report of 3 casesC L Barekman
Department of Pathology, Walter Reed Army Medical Center, Washington, DC 20307, USA
Arch Pathol Lab Med 125:951-3. 2001..Currently, the clinical implication of the coexpression of CD5 and CD10 is not known. We describe this finding to highlight the difficulty that may be encountered in classifying lymphomas in cases where this coexpression is present...
The blastic variant of mantle cell lymphoma arising in Waldeyer's tonsillar ringN S Aguilera
Department of Hematopathology, Armed Forces Institute of Pathology, Washington D C, USA
J Laryngol Otol 112:991-4. 1998..Immunohistochemistry and awareness of this type of lymphoma are helpful in differentiating it from other neoplasms...
CD45 (leukocyte common antigen) immunoreactivity in metastatic undifferentiated and neuroendocrine carcinoma: a potential diagnostic pitfallM A Nandedkar
Department of Hematopathology, Armed Forces Institute of Pathology, Washington, DC 20306 6000, USA
Mod Pathol 11:1204-10. 1998..It is best avoided by employing a panel of leukocyte and epithelial antigens and by use of electron microscopy, if possible...
Cutaneous follicle center lymphoma: a clinicopathologic study of 19 casesN S Aguilera
Department of Hematopathology, Armed Forces Institute of Pathology, Washington DC 20306 6000, USA
Mod Pathol 14:828-35. 2001..Follow-up showed no evidence of disease in 14/17 patients (4 to 137 mos). 3/17 patients are alive with disease (17 to 100 mo), and no patients died of disease...
